At this time, posts about Genexine are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 11,000 shares today. Genexine is known as a specialized company in biopharmaceutical development.

As of 11:30 AM on the 10th, Genexine's stock price is 79,500 KRW, up 0.76% from the previous day, with a trading volume of 307,412 shares, which is 52.09% of the 5-day average trading volume.

In addition to Genexine, posts from investors are also surging regarding Doosan Infracore (042670), Samsung Heavy Industries Preferred (010145), and Bridge Biotherapeutics (288330).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing